This medication combats oxidative stress, supports liver function, and promotes healthier skin from within
While the ATTAIN-1 trial successfully met its predetermined weight loss endpoints versus placebo, the weight loss percentage realized in the highest dose fell modestly short of investor expectations, with average weight loss of 12.4% versus placebo at 0.9%
However, we will be helping you make lifestyle changes throughout the course of treatment to help reduce weight gain when you have reached our goal and are ready to taper down your Semaglutide treatments
From the moment you walk in, you feel welcomed, supported, and genuinely cared for
Your provider will guide you on the dosing schedule best suited to your wellness goals
doi: 10.1093/hmg/dds228 10 NaulLManciniAPereiraSAGassawayBMLydeardJRMagnottoJCet al